Thu, May 5, 2022
Wed, May 4, 2022
Tue, May 3, 2022
Mon, May 2, 2022

David Amsellem Downgraded (TEVA) to Sell and Decreased Target to $7 on, May 4th, 2022


  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. l-and-decreased-target-to-7-on-may-4th-2022.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication

David Amsellem of Piper Sandler, Downgraded "Teva Pharmaceutical Industries Limited" (TEVA) to Sell and Decreased Target from $11 to $7 on, May 4th, 2022.

David has made no other calls on TEVA in the last 4 months.



There are 2 other peers that have a rating on TEVA. Out of the 2 peers that are also analyzing TEVA, 1 agrees with David's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Jasper Hellweg of "Argus Research" Downgraded from Strong Buy to Hold on, Thursday, January 27th, 2022


This is the rating of the analyst that currently disagrees with David


  • Balaji Prasad of "Barclays" Upgraded from Hold to Buy and Increased Target to $13 on, Tuesday, April 5th, 2022

Publication Contributing Sources